Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ROS study.

被引：0
|
作者：
Garcia-Alfonso, Pilar
Munoz Martin, Andres J.
Jimenez-Castro, Jeronimo
Jimenez-Fonseca, Paula
Pericay, Carles
Longo, Federico
Reyna, Carmen
Argiles, Guillem
Gonzalez Astorga, Beatriz
Jose Gomez-Reina, Maria
Ruiz Casado, Ana
Rodriguez-Salas, Nuria
Lopez-Lopez, Rafael
Carmona Bayonas, Alberto
Conde-Herrero, Veronica
Aranda, Enrique
机构：
[1] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
[2] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[3] Hosp Univ Virgen Rocio, Seville, Spain
[4] Hosp Univ Cent Asturias, Oviedo, Spain
[5] Hosp Sabadell, Corp Sanitaria Parc Tauli, Sabadell, Spain
[6] Inst Ramon & Cajal Invest Sanitaria IRICYS, Hosp Univ Ramon & Cajal, CIBERONC, Madrid, Spain
[7] Hosp Univ Reg & Virgen Victoria, Malaga, Spain
[8] Vall Hebron Univ Hosp & Inst Oncol VHIO, TTD Grp, CIBERONC, Barcelona, Spain
[9] Hosp Univ San Cecilio, Granada, Spain
[10] Hosp Univ Puerta Mar, Cadiz, Spain
[11] Hosp Univ Puerta Hierro, Dept Med Oncol, Madrid, Spain
[12] Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain
[13] Univ Clin Hosp, Dept Med Oncol, Madrid, Spain
[14] Univ Clin Hosp, Translat Med Oncol Grp, Madrid, Spain
[15] Univ Clin Hosp, Hlth Res Inst IDIS, Madrid, Spain
[16] Univ Santiago Compostela, Sch Med, CIBERONC, Santiago De Compostela, Spain
[17] Hosp Gen Univ Morales Meseguer, Murcia, Spain
[18] Hosp Univ Virgen Ias Nieves, Dept Med Oncol, Granada, Spain
[19] Univ Cordoba, Reina Sofia Hosp, IMIBIC, Inst Salud Carlos III,CIBERONC, Cordoba, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e15556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15556
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia
    Price, Timothy
    Burge, Matthew
    Chantrill, Lorraine
    Gibbs, Peter
    Pavlakis, Nick
    Shapiro, Jeremy
    Sjoquist, Katrin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 3 - 12
  • [32] Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study
    Chida, Keigo
    Kotani, Daisuke
    Nakamura, Yoshiaki
    Kawazoe, Akihito
    Kuboki, Yasutoshi
    Shitara, Kohei
    Kojima, Takashi
    Taniguchi, Hiroya
    Watanabe, Jun
    Endo, Itaru
    Yoshino, Takayuki
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [33] Phase I/II study of trifluridine/tipiracil plus XB2001 versus trifluridine/tipiracil in metastatic colorectal cancer
    Fumet, Jean-David
    Roussot, Nicolas
    Bertaut, Aurelie
    Limagne, Emeric
    Thibaudin, Marion
    Hervieu, Alice
    Zanetta, Sylvie
    Borg, Christophe
    Senellart, Helene
    Pernot, Simon
    Thuillier, Frederic
    Carnot, Aurelien
    Mineur, Laurent
    Chibaudel, Benoist
    Touchefeu, Yann
    Martin-Babau, Jerome
    Jary, Marine
    Labourey, Jean-Luc
    Rederstorff, Emilie
    Lepage, Come
    Ghiringhelli, Francois
    FUTURE ONCOLOGY, 2024, 20 (38) : 3077 - 3085
  • [34] A multicenter exploratory analysis of the possible predictive factors for trifluridine/tipiracil in refractory metastatic colorectal cancer
    Prejac, J.
    Omrcen, T.
    Radic, J.
    Vrdoljak, E.
    Frobe, A.
    Plestina, S.
    ANNALS OF ONCOLOGY, 2022, 33 : S316 - S316
  • [35] Sequential treatment with regorafenib and trifluridine/tipiracil in later-line refractory metastatic colorectal cancer: A real-world multicenter retrospective study.
    Signorelli, Carlo
    Schirripa, Marta
    Chilelli, Mario Giovanni
    Calegari, Maria Alessandra
    Basso, Michele
    Anghelone, Annunziato
    Lucchetti, Jessica
    Minelli, Alessandro
    Angotti, Lorenzo
    Gemma, Donatello
    Dell'Aquila, Emanuela
    Cosimati, Antonella
    Arrivi, Giulia
    Morelli, Cristina
    Corsi, Domenico Cristiano
    Saltarelli, Rosa
    Morandi, Maria Grazia
    Zoratto, Federica
    Santamaria, Fiorenza
    Ruggeri, Enzo Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 45 - 45
  • [36] A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal Cancer
    Zou, Jiayun
    Wang, Yuanyuan
    Xu, Jiayu
    Li, Jinna
    Wang, Tianzhuo
    Zhang, Ying
    Bai, Yibo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [37] Safety and efficacy of trifluridine/tipiracil monotherapy in metastatic colorectal cancer
    Aparicio Rubio, C.
    Monteagudo Santolaya, E.
    Cornejo Uixeda, S.
    Prieto Castello, M.
    Antonino de la Camara, G.
    Quintana Vergara, B.
    Sanchez Alcaraz, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 373 - 374
  • [38] Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution
    Kotani, Daisuke
    Shitara, Kohei
    Kawazoe, Akihito
    Fukuoka, Shota
    Kuboki, Yasutoshi
    Bando, Hideaki
    Okamoto, Wataru
    Kojima, Takashi
    Doi, Toshihiko
    Ohtsu, Atsushi
    Yoshino, Takayuki
    CLINICAL COLORECTAL CANCER, 2016, 15 (03) : E109 - E115
  • [39] Trifluridine/tipiracil in metastatic colorectal cancer: a guide to its use
    Lyseng-Williamson K.A.
    Burness C.B.
    Duggan S.T.
    Drugs & Therapy Perspectives, 2017, 33 (3) : 110 - 118
  • [40] Trifluridine/tipiracil in patients with refractory metastatic colorectal cancer in clinical routine in Germany: Interim results of the non-interventional study TACTIC
    Schwaner, I
    Goehler, T.
    Decker, T.
    Grundeis, M.
    Sauer, A.
    Fichter, C.
    Moorahrend, E.
    Kroening, H.
    Lipke, J.
    Kojouharoff, G.
    Frank, M.
    Hogrefe, C.
    Marschner, N.
    Potthoff, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 130 - 131
12345